EUR 0.0
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | 17.79 Million EUR | 22.89% |
2021 | 14.48 Million EUR | 2.64% |
2020 | 14.11 Million EUR | 42.19% |
2019 | 9.92 Million EUR | 134357.99% |
2018 | 7380.00 EUR | 5.43% |
2017 | 7000.00 EUR | -8.34% |
2016 | 7637.00 EUR | 42.35% |
2015 | 5365.00 EUR | 87.59% |
2014 | 2860.00 EUR | -99.93% |
2013 | 4.31 Million EUR | 84.63% |
2012 | 2.33 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | - EUR | 0.0% |
2022 FY | 17.79 Million EUR | 22.89% |
2022 Q4 | 17.79 Million EUR | 0.0% |
2022 Q2 | 17.38 Million EUR | 0.0% |
2021 Q2 | 13.99 Million EUR | 0.0% |
2021 FY | 14.48 Million EUR | 2.64% |
2021 Q4 | 14.48 Million EUR | 0.0% |
2020 Q4 | 14.11 Million EUR | 0.0% |
2020 Q2 | 11.31 Million EUR | 0.0% |
2020 FY | 14.11 Million EUR | 42.19% |
2019 Q4 | 9.92 Million EUR | 0.0% |
2019 FY | 9.92 Million EUR | 134357.99% |
2019 Q2 | 8.6 Million EUR | 0.0% |
2018 FY | 7380.00 EUR | 5.43% |
2018 Q4 | 7380.00 EUR | 0.0% |
2018 Q2 | 8023.00 EUR | 0.0% |
2017 Q4 | 7000.00 EUR | 0.0% |
2017 Q2 | 7081.00 EUR | 0.0% |
2017 FY | 7000.00 EUR | -8.34% |
2016 Q4 | 7637.00 EUR | 0.0% |
2016 Q2 | 6399.00 EUR | 0.0% |
2016 FY | 7637.00 EUR | 42.35% |
2015 Q4 | 5365.00 EUR | 0.0% |
2015 FY | 5365.00 EUR | 87.59% |
2015 Q2 | 2760.00 EUR | 0.0% |
2014 Q4 | 2860.00 EUR | 0.0% |
2014 FY | 2860.00 EUR | -99.93% |
2014 Q2 | 2272.00 EUR | 0.0% |
2013 Q4 | 4.31 Million EUR | 0.0% |
2013 FY | 4.31 Million EUR | 84.63% |
2012 FY | 2.33 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Crossject Société Anonyme | 33.9 Million EUR | 47.503% |
Spineway SA | 7.25 Million EUR | -145.239% |
Amplitude Surgical SA | 183.43 Million EUR | 90.298% |
Sartorius Stedim Biotech S.A. | 5.07 Billion EUR | 99.65% |
EssilorLuxottica Société anonyme | 21.63 Billion EUR | 99.918% |
bonyf N.V. | 411.93 Thousand EUR | -4220.331% |